New Stock News | Sinocelltech (688520.SH) Plans Hong Kong IPO; CSRC Requires Supplementary Explanation on the Necessity and Rationality of Listing in Hong Kong and Other Matters

Zhitong Finance APP has learned that on September 18, the China Securities Regulatory Commission issued the "Supplementary Materials Requirements for Overseas Offering and Listing Filing (September 14, 2026 - September 18, 2026)." The International Department of the China Securities Regulatory Commission issued supplementary materials requirements for a total of 6 companies. Among them, Sinocelltech (688520.SH) was required to provide supplementary explanations on the specific performance of regulatory procedures such as overseas investment and foreign exchange management involved in the establishment of overseas subsidiaries, and to further explain the necessity and reasonableness of this Hong Kong listing in light of the use of proceeds. According to disclosure by the Hong Kong Stock Exchange on May 22, Beijing Sinocelltech Biotechnology Group Co., Ltd. submitted a listing application to the Main Board of the Hong Kong Stock Exchange, with CITIC Securities as the sole sponsor.